RM
Revolution Medicines Inc
🇺🇸XNAS.RVMDUnited StatesHealthcare
$196.10USDdown -8.96 (-4.37%)ClosedDelayed8:26 AM
Price$196.10-8.96 (-4.37%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US76155X1000
- CUSIP
- 76155X100
Company
- Employees
- 883
- Headquarters
- Redwood City, United States
- Website
- https://www.revmed.com
- CEO
- Dr. Mark A. Goldsmith M.D., Ph.D.
Market
- Shares outstanding
- 214.3M
- Market cap
- $42.03B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $42.03B
- EPS LTM
- -$8.38
- P/E LTM
- -22.34
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$1.77B-117.75%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$1.59B-126.72%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.